ArticlePloS one2025

Hematological toxicity of anti-tumor antibody-drug conjugates: A retrospective pharmacovigilance study using the FDA adverse event reporting system.

Mei Rao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.